QuiVad

Home / Funds / Linden Advisors LP

Linden Advisors LP

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSince
Aurubis AGGermany1.75%August 4, 2026
Siltronic AGGermany0.89%August 12, 2026
AlvotechSweden0.82%August 12, 2026
Basic-Fit N.V.Netherlands0.67%August 7, 2026

History of disclosures

498 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
January 21, 2021Recipharm AB (publ)Sweden1.16%still open
January 21, 2021Audax Renovables, S.A.Spain0.99%still open
January 19, 2021Recipharm ABSweden1.23%still open
January 19, 2021Recipharm AB (publ)Sweden1.23%still open
January 19, 2021Morphosys AGGermany0.50%still open
January 14, 2021Recipharm ABSweden1.39%still open
January 14, 2021Recipharm AB (publ)Sweden1.39%still open
January 13, 2021Recipharm ABSweden1.43%still open
January 13, 2021Recipharm AB (publ)Sweden1.43%still open
January 12, 2021Recipharm ABSweden1.50%still open
January 12, 2021Recipharm AB (publ)Sweden1.50%still open
January 12, 2021Audax Renovables, S.A.Spain1.03%still open
January 12, 2021Morphosys AGGermany0.48%still open
January 11, 2021Audax Renovables, S.A.Spain0.91%still open
January 7, 2021Audax Renovables, S.A.Spain0.83%still open
January 7, 2021Morphosys AGGermany0.50%still open
January 6, 2021Audax Renovables, S.A.Spain0.79%still open
January 5, 2021Audax Renovables, S.A.Spain0.51%still open
December 21, 2020Recipharm ABSweden1.60%still open
December 21, 2020Recipharm AB (publ)Sweden1.60%still open
December 21, 2020Morphosys AGGermany0.48%still open
December 17, 2020Recipharm ABSweden1.54%still open
December 17, 2020Recipharm AB (publ)Sweden1.54%still open
December 16, 2020Recipharm ABSweden1.35%still open
December 16, 2020Recipharm AB (publ)Sweden1.35%still open
December 15, 2020Recipharm ABSweden1.15%still open
December 15, 2020Recipharm AB (publ)Sweden1.15%still open
December 15, 2020Morphosys AGGermany0.50%still open
December 14, 2020Recipharm ABSweden0.87%still open
December 14, 2020Recipharm AB (publ)Sweden0.87%still open
December 7, 2020Recipharm ABSweden0.73%still open
December 7, 2020Recipharm AB (publ)Sweden0.73%still open
December 3, 2020Recipharm ABSweden0.59%still open
December 3, 2020Recipharm AB (publ)Sweden0.59%still open
December 2, 2020Recipharm ABSweden0.60%still open
December 2, 2020Recipharm AB (publ)Sweden0.60%still open
December 1, 2020Recipharm ABSweden0.55%still open
December 1, 2020Recipharm AB (publ)Sweden0.55%still open
July 30, 2020Pharming Group N.V.Netherlands1.05%still open
June 11, 2020Pharming Group N.V.Netherlands1.18%still open
April 30, 2020Pharming Group N.V.Netherlands1.26%still open
April 21, 2020Pharming Group N.V.Netherlands1.18%still open
March 5, 2020Pharming Group N.V.Netherlands1.26%still open
March 3, 2020Pharming Group N.V.Netherlands1.32%still open
March 2, 2020Pharming Group N.V.Netherlands1.26%still open
March 2, 2020SmcpFrance0.45%March 4, 2020
February 26, 2020Pharming Group N.V.Netherlands1.32%still open
February 26, 2020SmcpFrance0.68%March 4, 2020
February 25, 2020SmcpFrance0.71%March 4, 2020
January 27, 2020Pharming Group N.V.Netherlands1.43%still open

The funds short on the same companies

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Linden Advisors LP, data as at August 12, 2026, https://www.quivad.com/detenteur/linden-advisors-lp?page=4